18 results
ARS
2022 FY
PNT
POINT Biopharma Global Inc.
1 May 23
Annual report to shareholders
1:52pm
clinical trials and upon any commercialization of any product candidates. Inadequate training in recognizing or managing the potential side effects … and to prevent security breaches, including costs related to deploying additional personnel and protection technologies, training employees, and engaging
DEF 14A
PNT
POINT Biopharma Global Inc.
28 Apr 22
Definitive proxy
8:36am
degree from the University of Toronto in 1988. He completed specialty training in urologic surgery and oncology from 1993 to 1996, received a Master’s … in Public Health in epidemiology from Columbia University in 1997, and completed his oncology training at Memorial Sloan-Kettering Cancer Center. Dr
424B3
19q3a01dz8m v40
31 Mar 22
Prospectus supplement
11:42am
POS AM
7cj346uadvoh wc9xa
25 Mar 22
Prospectus update (post-effective amendment)
8:41am
424B3
ggmqtfoamrpk8ne4dd
5 Aug 21
Prospectus supplement
4:26pm
424B3
c4rcgjj7i13sd7b vyy
9 Jun 21
Prospectus supplement
4:42pm
S-4/A
EX-10.18
7pkkov5u6 ur1gn95exp
30 Apr 21
Registration of securities issued in business combination transactions (amended)
9:53pm
S-4/A
3mv0xbkgh
30 Apr 21
Registration of securities issued in business combination transactions (amended)
9:53pm
S-4
EX-10.18
etqhj8
22 Mar 21
Registration of securities issued in business combination transactions
9:52pm
S-4
vwa83zu5uns55p8
22 Mar 21
Registration of securities issued in business combination transactions
9:52pm
8-K/A
EX-2.1
k00jvbppxs3f9h
18 Mar 21
Financial Statements and Exhibits
9:08am
- Prev
- 1
- Next